Fidelity Funds - Sustainable Health Care Fund W-Acc-GBPRegister to Unlock Ratings |
Performance History | 31/10/2024 |
Growth of 1,000 (GBP) | Advanced Graph |
Fund | 8.5 | 24.7 | -3.3 | 1.0 | 5.8 | |
+/-Cat | -9.0 | 15.2 | 1.3 | 4.1 | 2.1 | |
+/-B’mrk | - | 6.5 | -9.1 | 3.5 | -1.6 | |
Category: Sector Equity Healthcare | ||||||
Category Benchmark: Morningstar Gbl Health TME ... |
Key Stats | ||
NAV 22/11/2024 | GBP 2.99 | |
Day Change | 1.43% | |
Morningstar Category™ | Sector Equity Healthcare | |
IA (formerly IMA) Sector | Healthcare | |
ISIN | LU1033663300 | |
Fund Size (Mil) 31/10/2024 | EUR 1712.65 | |
Share Class Size (Mil) 22/11/2024 | GBP 112.79 | |
Max Initial Charge | - | |
Ongoing Charge 30/07/2024 | 1.04% |
Investment Objective: Fidelity Funds - Sustainable Health Care Fund W-Acc-GBP |
The fund aims to achieve capital growth over the long term. |
Returns | |||||||||||||
|
Management | ||
Manager Name Start Date | ||
Alex Gold 01/10/2017 | ||
Inception Date 11/03/2014 |
Advertisement |
Category Benchmark | |
Fund Benchmark | Morningstar Benchmark |
MSCI ACWI/Health Care NR EUR | Morningstar Gbl Health TME NR USD |
Target Market | ||||||||||||||||||||
|
Portfolio Profile for Fidelity Funds - Sustainable Health Care Fund W-Acc-GBP | 30/09/2024 |
|
|
Top 5 Holdings | Sector | % |
UnitedHealth Group Inc | Healthcare | 9.43 |
Boston Scientific Corp | Healthcare | 7.11 |
Eli Lilly and Co | Healthcare | 6.68 |
Novo Nordisk AS Class B | Healthcare | 5.84 |
Stryker Corp | Healthcare | 4.51 |
Increase Decrease New since last portfolio | ||
Fidelity Funds - Sustainable Health Care Fund W-Acc-GBP |